These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2139937)
1. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus]. Vallée E; Joly-Guillou ML; Bergogne-Berezin E Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937 [TBL] [Abstract][Full Text] [Related]
2. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus. Bergogne-Berezin E; Joly-Guillou ML J Antimicrob Chemother; 1986 Dec; 18 Suppl E():35-9. PubMed ID: 3546246 [TBL] [Abstract][Full Text] [Related]
3. [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus]. Joly-Guillou ML; Bergogne-Bérézin E Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):625-8. PubMed ID: 3534756 [TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ]. Bergogne-Berezin E; Joly-Guillou ML; Verin-Prevost C Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):506-9. PubMed ID: 6289227 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species. Suh B; Shapiro T; Jones R; Satishchandran V; Truant AL Diagn Microbiol Infect Dis; 1995 Feb; 21(2):111-4. PubMed ID: 7628190 [TBL] [Abstract][Full Text] [Related]
6. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli]. Thabaut A; Meyran M; Huerre M Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217 [TBL] [Abstract][Full Text] [Related]
7. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer]. Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of antimicrobial agents against Acinetobacter calcoaceticus. Joly-Guillou ML; Bergogne-Berezin E Drugs Exp Clin Res; 1986; 12(12):949-52. PubMed ID: 3471431 [TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus]. Joly-Guillou ML; Bergogne-Berezin E Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142 [TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776]. Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Lee K; Lim CH; Cho JH; Lee WG; Uh Y; Kim HJ; Yong D; Chong Y; Yonsei Med J; 2006 Oct; 47(5):634-45. PubMed ID: 17066507 [TBL] [Abstract][Full Text] [Related]
15. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex]. Villar HE; Laurino G; Hoffman M Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood. Traub WH; Spohr M; Bauer D Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872 [TBL] [Abstract][Full Text] [Related]
17. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin. Digranes A; Dibb WL; Benonisen E; Salveson A Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281 [TBL] [Abstract][Full Text] [Related]
18. [Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp]. Villar HE; Laurino G; Arena MF; Hoffman M Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):140-3. PubMed ID: 9235053 [TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii]. Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin. Chin NX; Neu HC Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]